Aaron Marx
Overview
Aaron Marx is a senior counsel in the International Trade Group of Crowell & Moring and resident in the firm's Washington, D.C. office.
Career & Education
- Department of Homeland Security
Attorney-Advisor, Office of International Trade, U.S. Customs and Border Protection, 2010–2015
- Department of Homeland Security
- University of Michigan, B.S., chemical engineering, 1998
- Brooklyn Law School, J.D., 2010
- District of Columbia
- New York
Aaron's Insights
Client Alert | 5 min read | 04.07.26
On April 2, 2026, President Trump issued a Proclamation invoking Section 232 of the Trade Expansion Act of 1962, as amended (19 U.S.C. § 1862), to impose tariffs on imports of patented pharmaceuticals, biologics, and associated ingredients into the United States. The action affects pharmaceutical manufacturers, importers, and supply chain participants.
Webinar | 03.02.26
Speaking Engagement | 03.02.26
"Securing Rights to IEEPA Tariff Refunds," Crowell & Moring Webinar.
Insights
Thomson Reuters Names 16 Crowell Lawyers as “Stand-out Lawyers”
|03.07.23
Firms at Risk of Monetary Penalty for Breaches of UK Financial Sanctions Imposed on Russia
|03.31.25
Crowell & Moring’s International Trade Law
Authors:
House Introduces Trade Legislation on GSP and MTB as Part of America COMPETES Act
|01.27.22
Crowell & Moring’s International Trade Law
CBP Issues Liquidation Extension Request and Protest Guidance for Pending Section 301 Litigation
|12.15.21
Crowell & Moring’s International Trade Law
New Infrastructure Investment and Jobs Act Revives Chemicals Superfund Excise Taxes
|12.09.21
Crowell & Moring’s International Trade Law
- |
07.02.21
Crowell & Moring’s International Trade Law
- |
05.20.21
Crowell & Moring’s International Trade Law
- |
10.02.19
Crowell & Moring's International Trade Law
ITC Publishes Final Rule Regarding Filing of Miscellaneous Tariff Bill (MTB) Petitions
|09.03.19
Crowell & Moring's Retail & Consumer Products Law Observer
Get Ready for MTB 2019 – The Process for Requesting the Reduction or Elimination of Import Duties
|02.28.19
Crowell & Moring's Retail & Consumer Products Law Observer
MTB Questionnaires Issue and ITC Fact-Finding Investigation Commences
|02.13.19
Crowell & Moring's International Trade Law
Aaron's Insights
Client Alert | 5 min read | 04.07.26
On April 2, 2026, President Trump issued a Proclamation invoking Section 232 of the Trade Expansion Act of 1962, as amended (19 U.S.C. § 1862), to impose tariffs on imports of patented pharmaceuticals, biologics, and associated ingredients into the United States. The action affects pharmaceutical manufacturers, importers, and supply chain participants.
Webinar | 03.02.26
Speaking Engagement | 03.02.26
"Securing Rights to IEEPA Tariff Refunds," Crowell & Moring Webinar.



